Orion Biotech Opportunities (Orion Biotech Opportunities) Interest Expense : $0.00 Mil (TTM As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Orion Biotech Opportunities Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Orion Biotech Opportunities's interest expense for the three months ended in Dec. 2022 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Orion Biotech Opportunities's Operating Income for the three months ended in Dec. 2022 was $ -0.20 Mil. Orion Biotech Opportunities's Interest Expense for the three months ended in Dec. 2022 was $ 0.00 Mil. Orion Biotech Opportunities has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Orion Biotech Opportunities Interest Expense Historical Data

The historical data trend for Orion Biotech Opportunities's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Biotech Opportunities Interest Expense Chart

Orion Biotech Opportunities Annual Data

Trend

Dec21

Dec22

Interest Expense

Orion Biotech Opportunities Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Interest Expense	Get a 7-Day Free Trial			-	-	-	-	-

Orion Biotech Opportunities Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Orion Biotech Opportunities (OTCPK:ORIAU) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Orion Biotech Opportunities's Interest Expense for the three months ended in Dec. 2022 was $0.00 Mil. Its Operating Income for the three months ended in Dec. 2022 was $-0.20 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2022 was $0.00 Mil.

Orion Biotech Opportunities's Interest Coverage for the quarter that ended in Dec. 2022 is calculated as

Orion Biotech Opportunities had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Orion Biotech Opportunities Corp has no debt.